Median Diagnostics Inc. (XKON:233250)
South Korea · Delayed Price · Currency is KRW 4,900.00
0.00 (0.00%)
At close: Oct 2, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 8.56 billion as of October 2, 2026. Its market cap has decreased by -64.21% in one year.
Market Cap
8.56B
Enterprise Value
n/a
Revenue
7.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,900.00
ChartMarket Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 8.56B, a decrease of -61.26%. That is a compound annual growth rate of -9.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 8.56B | -57.32% |
| Dec 30, 2025 | 20.05B | -20.83% |
| Dec 30, 2024 | 25.32B | -9.32% |
| Dec 28, 2023 | 27.93B | -44.77% |
| Dec 29, 2022 | 50.56B | -27.35% |
| Dec 30, 2021 | 69.60B | -3.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 192.21B |
| GENINUS | 82.33B |
| GC Medical Science | 79.68B |
| Inventera | 76.77B |
| Protia | 76.38B |
| Cytogen | 74.24B |
| HLB Panagene | 56.00B |
| Seoulin Bioscience | 36.40B |